Rinda  Sama net worth and biography

Rinda Sama Biography and Net Worth

COO of Axonics
Rinda K. Sama serves as Chief Operating Officer of the Company. From May 2014 to August 2018, Mr. Sama served as our Vice President, Operations and Quality. From June 2011 to May 2014, Mr. Sama served as Director, Operations and Quality of Vessix Vascular, Inc. Mr. Sama holds a B.S. in Biomedical Engineering from Karnatak University Dharwad, a M.S. in Biomedical Engineering from the University of Southern California and a M.B.A from the University of California, Irvine.

What is Rinda Sama's net worth?

The estimated net worth of Rinda Sama is at least $3.96 million as of February 21st, 2023. Mr. Sama owns 55,854 shares of Axonics stock worth more than $3,964,517 as of December 3rd. This net worth approximation does not reflect any other assets that Mr. Sama may own. Additionally, Mr. Sama receives an annual salary of $888,200.00 as COO at Axonics. Learn More about Rinda Sama's net worth.

How old is Rinda Sama?

Mr. Sama is currently 45 years old. There are 7 older executives and no younger executives at Axonics. The oldest executive at Axonics is Mr. Raymond W. Cohen, Co-Founder, Chief Executive Officer and Director, who is 65 years old. Learn More on Rinda Sama's age.

What is Rinda Sama's salary?

As the COO of Axonics, Inc., Mr. Sama earns $888,200.00 per year. There are 3 executives that earn more than Mr. Sama. The highest earning executive at Axonics is Mr. Raymond W. Cohen, Co-Founder, Chief Executive Officer and Director, who commands a salary of $1,750,000.00 per year. Learn More on Rinda Sama's salary.

How do I contact Rinda Sama?

The corporate mailing address for Mr. Sama and other Axonics executives is 26 TECHNOLOGY DRIVE, IRVINE CA, 92618. Axonics can also be reached via phone at (949) 396-6322 and via email at [email protected]. Learn More on Rinda Sama's contact information.

Has Rinda Sama been buying or selling shares of Axonics?

Rinda Sama has not been actively trading shares of Axonics during the last ninety days. Most recently, Rinda Sama sold 19,929 shares of the business's stock in a transaction on Tuesday, February 21st. The shares were sold at an average price of $56.27, for a transaction totalling $1,121,404.83. Following the completion of the sale, the chief operating officer now directly owns 55,854 shares of the company's stock, valued at $3,142,904.58. Learn More on Rinda Sama's trading history.

Who are Axonics' active insiders?

Axonics' insider roster includes Juliet Bakker (Director), Raymond Cohen (Co-Founder, Chief Executive Officer and Director), Danny Dearen (Insider), Alfred Ford, Jr. (Insider), Kari Keese (CFO), Jane Kiernan (Director), Esteban Lopez (Director), Robert Mcnamara (Director), Karen Noblett (Insider), Rinda Sama (COO), and John Woock (CMO). Learn More on Axonics' active insiders.

Are insiders buying or selling shares of Axonics?

During the last year, insiders at the sold shares 8 times. They sold a total of 92,797 shares worth more than $6,275,226.67. The most recent insider tranaction occured on October, 2nd when CFO Kari Leigh Keese sold 2,961 shares worth more than $205,523.01. Insiders at Axonics own 1.9% of the company. Learn More about insider trades at Axonics.

Information on this page was last updated on 10/2/2024.

Rinda Sama Insider Trading History at Axonics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/21/2023Sell19,929$56.27$1,121,404.8355,854View SEC Filing Icon  
1/31/2023Sell13,425$61.15$820,938.7580,858View SEC Filing Icon  
8/10/2022Sell33,850$69.56$2,354,606.0054,658View SEC Filing Icon  
2/3/2022Sell11,882$48.25$573,306.50View SEC Filing Icon  
6/10/2021Sell1,362$60.02$81,747.2429,898View SEC Filing Icon  
6/8/2021Sell1,000$60.23$60,230.0029,898View SEC Filing Icon  
5/11/2021Sell25,000$53.35$1,333,750.0041,917View SEC Filing Icon  
4/15/2021Sell73,848$59.06$4,361,462.8879,168View SEC Filing Icon  
2/1/2021Sell4,262$51.42$219,152.04107,223View SEC Filing Icon  
1/26/2021Sell3,217$53.58$172,366.86100,440View SEC Filing Icon  
12/8/2020Sell8,763$46.31$405,814.5391,201View SEC Filing Icon  
11/25/2020Sell10,000$43.91$439,100.0099,964View SEC Filing Icon  
11/3/2020Sell300$50.00$15,000.00127,374View SEC Filing Icon  
10/29/2020Sell12,863$48.03$617,809.89127,374View SEC Filing Icon  
8/6/2020Sell20,000$43.40$868,000.00153,828View SEC Filing Icon  
7/28/2020Sell13,708$43.10$590,814.80171,293View SEC Filing Icon  
7/21/2020Sell14,400$40.81$587,664.00199,931View SEC Filing Icon  
5/19/2020Sell20$39.00$780.00186,274View SEC Filing Icon  
4/30/2020Sell5,000$32.20$161,000.00186,294View SEC Filing Icon  
4/2/2020Sell5,000$23.72$118,600.00191,294View SEC Filing Icon  
3/5/2020Sell5,000$38.12$190,600.00196,294View SEC Filing Icon  
2/6/2020Sell5,000$29.14$145,700.00201,294View SEC Filing Icon  
1/2/2020Sell5,000$27.42$137,100.00200,627View SEC Filing Icon  
12/5/2019Sell5,000$23.92$119,600.00205,627View SEC Filing Icon  
10/30/2019Sell5,000$24.70$123,500.00
10/1/2019Sell5,000$26.61$133,050.00
5/9/2019Sell13,345$28.03$374,060.35View SEC Filing Icon  
See Full Table

Rinda Sama Buying and Selling Activity at Axonics

This chart shows Rinda Sama's buying and selling at Axonics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Axonics Company Overview

Axonics logo
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Read More

Today's Range

Now: $70.98
Low: $70.37
High: $71.05

50 Day Range

MA: $70.32
Low: $69.26
High: $70.98

2 Week Range

Now: $70.98
Low: $55.09
High: $71.05

Volume

4,233,300 shs

Average Volume

713,457 shs

Market Capitalization

$3.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82